Total debt declined to $449.1M from $606.5M over ten quarters, lowering the debt-to-equity ratio to 0.56, while cash thinned to $139.3M and goodwill of $524.0M dominates the asset base.
NeoGenomics, Inc. (NEO) balance sheet — 26-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Total Current Assets | 410.08M | 376.29M | 596.02M | 596.81M | 605.29M | 681.51M | 448.73M | 290.74M | 103.67M | 84.96M | 78.83M | 99.03M | 58.74M | 27.49M | 18.58M | 13.18M | 8.74M | 8.52M | 4.36M | 4.15M | 1.9M | 680.55K | 196.28K | 102.13K | 61.39K | 78.52K | 186 |
| Cash & Short-Term Investments | 139.28M | 159.62M | 386.84M | 415.2M | 437.99M | 515.39M | 296.26M | 173.02M | 9.81M | 12.82M | 12.53M | 23.42M | 33.69M | 4.83M | 1.87M | 2.63M | 1.1M | 1.63M | 468.17K | 210.57K | 126.27K | 10.94K | 112.55K | 25.05K | 0 | 77.22K | 186 |
| Cash Only | 139.28M | 159.62M | 367.01M | 342.49M | 263.18M | 316.83M | 228.71M | 173.02M | 9.81M | 12.82M | 12.53M | 23.42M | 33.69M | 4.83M | 1.87M | 2.63M | 1.1M | 1.63M | 468.17K | 210.57K | 126.27K | 10.94K | 112.55K | 25.05K | 0 | 77.22K | 186 |
| Short-Term Investments | 0 | 0 | 19.83M | 72.72M | 174.81M | 198.56M | 67.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 213.41M | 159.24M | 150.54M | 131.26M | 119.71M | 112.13M | 106.84M | 95.24M | 76.92M | 60.43M | 55.51M | 48.94M | 20.48M | 18.65M | 14.03M | 7.89M | 5.24M | 4.63M | 2.91M | 3.24M | 1.55M | 551.1K | 56.49K | 63.86K | 40.08K | 0 | 0 |
| Days Sales Outstanding | 82.88 | 79.91 | 83.18 | 80.98 | 85.72 | 84.5 | 87.74 | 85.03 | 101.45 | 91.8 | 83.01 | 179 | 85.83 | 102.43 | 85.56 | 66.26 | 55.6 | 57.37 | 53.13 | 102.69 | 87.35 | 106.71 | 36.95 | 63 | 156.48 | - | - |
| Inventory | 25.5M | 28.57M | 26.75M | 24.16M | 24.28M | 23.39M | 29.53M | 14.4M | 8.65M | 7.47M | 6.25M | 5.11M | 2.62M | 2.3M | 1.86M | 1.2M | 887K | 601.8K | 491.46K | 304.75K | 117.36K | 60K | 15.12K | 10.59K | 19.31K | 0 | 0 |
| Days Inventory Outstanding | 22.89 | 23.44 | 26.35 | 25.41 | 27.53 | 28.73 | 41.68 | 24.8 | 21.12 | 19.73 | 17.07 | 33.27 | 20.6 | 24.18 | 20.54 | 18.24 | 17.42 | 15.41 | 19.18 | 20.14 | 15.53 | 18.43 | 9.57 | 8.03 | 37.1 | - | - |
| Other Current Assets | 9.12M | 7.42M | 11.72M | 8.2M | 8.08M | 18.24M | 4.55M | 1.75M | 561K | 1M | 4.54M | 4.89M | 1.96M | 1.7M | 820K | 1.45M | 1.52M | 1.66M | 482.41K | 400.17K | 102.17K | 58.51K | 12.12K | 2.63K | 2K | 1.3K | 0 |
| Total Non-Current Assets | 966.83M | 983.54M | 1.04B | 1.08B | 1.13B | 1.19B | 539.6M | 418.77M | 401.35M | 258.38M | 258.29M | 268.93M | 22.36M | 12.43M | 11.49M | 6.77M | 4.91M | 4.43M | 2.94M | 2.37M | 1.24M | 399.55K | 395.72K | 404.91K | 386.45K | 2.83K | 0 |
| Property, Plant & Equipment | 170.21M | 163.28M | 173.69M | 183.78M | 198.61M | 211.66M | 151.89M | 90.68M | 60.89M | 36.5M | 34.04M | 34.58M | 15.08M | 9.69M | 8.61M | 6.64M | 4.84M | 4.34M | 2.88M | 2.11M | 1.2M | 381.56K | 393.04K | 397.69K | 382.54K | 2.83K | 0 |
| Fixed Asset Turnover | 4.77x | 4.45x | 3.80x | 3.22x | 2.57x | 2.29x | 2.93x | 4.51x | 4.55x | 6.58x | 7.17x | 2.89x | 5.77x | 6.86x | 6.96x | 6.55x | 7.10x | 6.79x | 6.96x | 5.46x | 5.39x | 4.94x | 1.42x | 0.93x | 0.24x | 0.35x | - |
| Goodwill | 524M | 524.34M | 522.77M | 522.77M | 522.77M | 527.12M | 211.08M | 198.6M | 197.89M | 147.02M | 147.02M | 146.42M | 2.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 263.63M | 286.53M | 339.68M | 373.13M | 408.26M | 442.32M | 120.65M | 126.64M | 140.03M | 74.17M | 77.06M | 87.8M | 4.21M | 2.58M | 2.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 31K | 236K | 29.55M | 153K | -22.46M | -6.31M | -14.97M | -16.67M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 9M | 9.39M | 5.89M | 4.74M | -29.67M | -48.54M | 21.01M | 2.69M | 2.54M | 689K | 174K | 129K | 141K | 154K | 83K | 129K | 74K | 85.6K | 64.51K | 260.57K | 33.9K | 18K | 2.68K | 7.22K | 3.92K | 0 | 0 |
| Total Assets | 1.38B | 1.36B | 1.64B | 1.68B | 1.74B | 1.87B | 988.33M | 709.51M | 505.01M | 343.34M | 337.12M | 367.95M | 81.11M | 39.92M | 30.07M | 19.95M | 13.65M | 12.95M | 7.3M | 6.52M | 3.13M | 1.08M | 592K | 507.04K | 447.84K | 81.34K | 186 |
| Asset Turnover | 0.58x | 0.53x | 0.40x | 0.35x | 0.29x | 0.26x | 0.45x | 0.58x | 0.55x | 0.70x | 0.72x | 0.27x | 1.07x | 1.67x | 1.99x | 2.18x | 2.52x | 2.28x | 2.74x | 1.76x | 2.07x | 1.75x | 0.94x | 0.73x | 0.21x | 0.01x | 1357.01x |
| Asset Growth % | -35.74% | -16.98% | -2.57% | -3.38% | -6.94% | 89.19% | 39.3% | 40.49% | 47.09% | 1.85% | -8.38% | 353.67% | 103.19% | 32.74% | 50.74% | 46.14% | 5.45% | 77.45% | 11.88% | 108.21% | 189.97% | 82.45% | 16.76% | 13.22% | 450.56% | 43632.8% | - |
| Total Current Liabilities | 116.17M | 88.3M | 301.24M | 96.3M | 89.93M | 87.23M | 73.18M | 63.9M | 60.92M | 35.06M | 59.91M | 40.06M | 14.62M | 14.32M | 17.76M | 11.44M | 9.17M | 5.78M | 4.39M | 3.36M | 2.63M | 665.85K | 1.02M | 284.84K | 424.49K | 186.22K | 125.03K |
| Accounts Payable | 32.92M | 23.09M | 21.61M | 20.33M | 20.51M | 17.92M | 24.96M | 19.57M | 17.78M | 10.45M | 16.78M | 12.46M | 6.29M | 4.18M | 3.61M | 2.53M | 1.93M | 1.97M | 1.51M | 1.8M | 697.75K | 463.64K | 96.21K | 70.34K | 119.84K | 19.3K | 10.46K |
| Days Payables Outstanding | 37.59 | 18.95 | 21.29 | 21.39 | 23.26 | 22 | 35.24 | 33.69 | 43.41 | 27.58 | 45.81 | 81.17 | 49.56 | 43.9 | 39.9 | 38.37 | 37.96 | 50.42 | 59.02 | 118.9 | 92.31 | 142.45 | 60.87 | 53.31 | 230.27 | - | 51.39 |
| Short-Term Debt | 0 | 4.78M | 200.78M | 0 | 0 | 1.14M | 2.84M | 13.81M | 14.17M | 3.8M | 3.84M | 9.47M | 66K | 4.28M | 8.46M | 3.9M | 3.44M | 552K | 1.15M | 242.97K | 1.73M | 0 | 0 | 0 | 13.52K | 0 | 0 |
| Deferred Revenue (Current) | 828K | 0 | 409K | 2.13M | 7.56M | 5.19M | 4.03M | 1.61M | 927K | -15.63M | -12.6M | -13.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 944.58K | 200.59K | 100K | 110K | 110K | 100K | 0 | 0 |
| Other Current Liabilities | 0 | 60.43M | 62.44M | 53.16M | 15.07M | 16.66M | 0 | 7.55M | 2.69M | 1.41M | 0 | 0 | 0 | 741K | 669K | 773K | 460K | 465.07K | 358.26K | 949.08K | 67.1K | 59.66K | 740K | 58.67K | 191.14K | 157.31K | 114.57K |
| Current Ratio | 3.53x | 4.26x | 1.98x | 6.20x | 6.73x | 7.81x | 6.13x | 4.55x | 1.70x | 2.42x | 1.32x | 2.47x | 4.02x | 1.92x | 1.05x | 1.15x | 0.95x | 1.48x | 0.99x | 1.24x | 0.72x | 1.02x | 0.19x | 0.36x | 0.14x | 0.42x | 0.00x |
| Quick Ratio | 3.31x | 3.94x | 1.89x | 5.95x | 6.46x | 7.54x | 5.73x | 4.32x | 1.56x | 2.21x | 1.21x | 2.34x | 3.84x | 1.76x | 0.94x | 1.05x | 0.86x | 1.37x | 0.88x | 1.14x | 0.68x | 0.93x | 0.18x | 0.32x | 0.10x | 0.42x | 0.00x |
| Cash Conversion Cycle | 68.18 | 84.41 | 88.25 | 85 | 89.99 | 91.22 | 94.18 | 76.14 | 79.16 | 83.95 | 54.27 | 131.09 | 56.87 | 82.72 | 66.2 | 46.13 | 35.06 | 22.37 | 13.29 | 3.93 | 10.56 | -17.3 | -14.36 | 17.72 | -36.69 | - | - |
| Total Non-Current Liabilities | 460.11M | 434.97M | 434.46M | 643.39M | 652.08M | 674.27M | 220.85M | 138.19M | 123.65M | 102.74M | 90.61M | 89.78M | 6.08M | 3.88M | 3.1M | 2.61M | 1.35M | 1.53M | 1.4M | 837.08K | 448.95K | 1.41M | 206.21K | 590K | 233.36K | 19.3K | 10.46K |
| Long-Term Debt | 374.69M | 404.68M | 340.33M | 538.2M | 535.32M | 532.48M | 168.12M | 91.83M | 98.13M | 91.15M | 92.06M | 52.34M | 64K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 590K | 0 | 0 | 0 |
| Capital Lease Obligations | 261.44M | 62.82M | 60.84M | 67.87M | 68.95M | 72.29M | 43.26M | 27.23M | 0 | 5.28M | 5.38M | 5.04M | 5.19M | 3.29M | 3.1M | 2.61M | 1.35M | 1.53M | 1.4M | 837.08K | 448.95K | 1.41M | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 68.59M | 18.22M | 21.51M | 24.29M | 34.75M | 55.48M | 5.42M | 15.57M | 22.46M | 6.31M | 14.97M | 32.41M | 821K | 588K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 867K | -51.14M | 11.77M | 13.03M | 13.05M | 13.03M | 3.34M | 2.4M | 3.06M | 6.97M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -272 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 576.28M | 523.27M | 735.7M | 739.69M | 742.01M | 761.5M | 294.04M | 202.1M | 184.57M | 137.81M | 150.52M | 129.84M | 20.7M | 18.2M | 20.86M | 14.05M | 10.52M | 7.3M | 5.79M | 4.2M | 3.08M | 2.08M | 1.02M | 874.84K | 424.49K | 186.22K | 125.03K |
| Total Debt | 449.14M | 472.28M | 605.33M | 611.68M | 610.93M | 612.79M | 218.22M | 132.88M | 112.3M | 105.42M | 106.17M | 71.38M | 8.48M | 10.36M | 13.77M | 8.61M | 6.79M | 3.56M | 3.19M | 1.08M | 543.38K | 0 | 0 | 590K | 13.52K | 0 | 0 |
| Net Debt | 309.86M | 312.66M | 238.32M | 269.19M | 347.75M | 295.96M | -10.49M | -40.14M | 102.49M | 92.6M | 93.64M | 47.96M | -25.21M | 5.53M | 11.9M | 5.99M | 5.69M | 1.93M | 2.72M | 869.47K | 417.11K | -10.94K | -112.55K | 564.95K | 13.52K | -77.22K | -186 |
| Debt / Equity | 0.56x | 0.56x | 0.67x | 0.65x | 0.61x | 0.55x | 0.31x | 0.26x | 0.35x | 0.51x | 0.57x | 0.30x | 0.14x | 0.48x | 1.49x | 1.46x | 2.16x | 0.63x | 2.12x | 0.47x | 9.97x | - | - | - | 0.58x | - | - |
| Debt / EBITDA | 24.80x | 270.65x | - | - | - | - | 10.04x | 3.07x | 3.53x | 4.14x | 4.12x | 47.36x | 1.08x | 1.37x | 2.74x | 5.14x | - | - | - | - | 1.22x | - | - | - | - | - | - |
| Net Debt / EBITDA | 17.11x | 179.17x | - | - | - | - | -0.48x | -0.93x | 3.23x | 3.63x | 3.63x | 31.82x | -3.21x | 0.73x | 2.37x | 3.57x | - | - | - | - | 0.93x | - | - | - | - | - | - |
| Interest Coverage | -10.15x | -28.38x | -11.19x | -13.06x | -20.02x | -0.83x | -1.00x | 1.98x | 1.61x | 0.71x | 0.22x | -4.26x | 2.25x | 3.21x | 1.06x | -0.53x | -4.17x | -3.25x | -2.87x | - | 0.43x | -4.07x | - | -11.92x | -2.82x | - | - |
| Total Equity | 800.64M | 836.56M | 902.34M | 941.54M | 998.02M | 1.11B | 694.29M | 507.41M | 320.44M | 205.53M | 186.6M | 238.11M | 60.41M | 21.71M | 9.22M | 5.9M | 3.13M | 5.64M | 1.5M | 2.32M | 54.51K | -994.94K | -426.65K | -367.8K | 23.34K | -104.87K | -124.84K |
| Equity Growth % | -26.48% | -7.29% | -4.16% | -5.66% | -9.95% | 59.63% | 36.83% | 58.35% | 55.91% | 10.15% | -21.64% | 294.19% | 178.22% | 135.58% | 56.28% | 88.1% | -44.45% | 275.94% | -35.36% | 4159.67% | 105.48% | -133.2% | -16% | -1675.51% | 122.26% | 16% | - |
| Book Value per Share | 6.23 | 6.53 | 7.12 | 7.50 | 8.03 | 9.24 | 6.21 | 4.90 | 3.50 | 2.59 | 2.41 | 19.67 | 5.39 | 2.06 | 0.95 | 0.69 | 0.42 | 0.81 | 0.24 | 0.37 | 0.01 | -0.22 | -0.10 | -0.13 | 0.03 | -0.14 | -0.80 |
| Total Shareholders' Equity | 800.64M | 836.56M | 902.34M | 941.54M | 998.02M | 1.11B | 694.29M | 507.41M | 320.44M | 205.53M | 186.6M | 238.11M | 60.41M | 21.71M | 9.22M | 5.9M | 3.13M | 5.64M | 1.5M | 2.32M | 54.51K | -994.94K | -426.65K | -367.8K | 23.34K | -104.87K | -124.84K |
| Common Stock | 131K | 129K | 128K | 127K | 127K | 124K | 112K | 105K | 94K | 80K | 79K | 76K | 60K | 49K | 45K | 43K | 37K | 37.19K | 32.12K | 31.39K | 27.06K | 22.84K | 21.54K | 18.45K | 4.48K | 405K | 1.32M |
| Retained Earnings | -456.22M | -433.81M | -325.78M | -247.06M | -159.09M | -14.84M | -7.18M | -11.36M | -51.26M | -57.47M | -52.46M | -21.94M | -19.41M | -20.54M | -22.57M | -22.64M | -21.46M | -18.16M | -15.91M | -14.53M | -11.15M | -11.02M | -10.02M | -8.67M | -8.67M | -8.08M | -1.45M |
| Treasury Stock | -25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 4K | 4K | -206K | -1.67M | -3.9M | -638K | 10K | -1.62M | -579K | 274K | -27.1M | -26.53M | -19.82M | -14.48M | -10.29M | -6.65M | -4.57M | -2.79M | 0 | 0 | -122.62K | -2.69K | -28.62K | -535.76K | -38.36K | -3.79M | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying NEO stock.
As of 2025, NeoGenomics, Inc. (NEO) had total assets of $1.36B including $376.3M in current assets.
NeoGenomics, Inc. (NEO) carries total debt of $472.3M, offset by $159.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
NeoGenomics, Inc. (NEO) has total shareholders' equity (book value) of $836.6M ($6.53 book value per share). Book value represents the net worth of the company belonging to common stock holders.
NeoGenomics, Inc. (NEO) reported a current ratio of 4.26x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Thin cash buffer against debt
Metrics are mathematically derived from official filings.
Balance Sheet Shifted Toward Lower Leverage
Based on NEO's reported figures, total debt fell from $606.5M in 2024Q2 to $449.1M in 2026Q3 while equity rose from $915.9M to $800.6M, reflecting a deleveraging trend over the ten-quarter window.
The reduction in debt appears to have been funded partly from a cash drawdown, with cash falling from $355.1M to $139.3M over the same period. This pattern suggests the company prioritized paying down obligations over building reserves, which may improve the leverage profile but reduces its shock absorption capacity. Investors should monitor whether further debt reduction can be sustained without additional cash burn.
Leverage Moderate but Refinancing Visibility Limited
As reported in financial statements, NEO's debt-to-equity ratio improved from 0.66 in 2024Q2 to 0.56 in 2026Q3, with total debt of $449.1M against equity of $800.6M.
A D/E near 0.56 is moderate for a company with persistent operating losses, suggesting leverage is not currently excessive relative to book equity. However, the book equity base is heavily influenced by goodwill of $524.0M, so tangible equity may be considerably lower than headline figures imply. The filings provided do not disclose maturity schedules, so refinancing risk cannot be fully assessed from this data.
Current Ratio Strong but Cash Thinning
Based on NEO's reported figures, the current ratio stands at 3.53 in 2026Q3, though cash has declined to $139.3M from $346.2M a year earlier, narrowing the liquidity cushion.
A current ratio above 3.5 indicates substantial short-term asset coverage, but the ratio is partly sustained by receivables and inventory whose conversion to cash is not fully visible in the supplied data. The sharp cash decline in 2025Q1 coincided with debt reduction, leaving less direct liquidity against operating cash swings. Investors should monitor whether cash stabilizes given the historically volatile free cash flow profile.
Goodwill Dominates Asset Base
According to reported figures, goodwill of $524.0M represents a large share of NEO's roughly $1.4B total assets, while net PP&E remains modest at $170.2M.
The asset mix suggests a business whose balance sheet value rests heavily on acquired intangibles rather than physical capacity, which is consistent with a diagnostics services model. Goodwill has been essentially flat across the period, so impairment risk depends on whether future earnings support the carrying value given persistent operating losses. PP&E has been broadly stable, indicating capital intensity is not the primary driver of balance sheet change.
Goodwill Could Overstate Balance Sheet Strength
Based on reported figures, NEO's accumulated deficit of -$456.2M and goodwill of $524.0M together suggest the headline equity of $800.6M may be more dependent on acquisition accounting than on retained operating value.
Because retained earnings are deeply negative, the positive equity position appears to rest on paid-in capital rather than accumulated profits. If goodwill were ever written down, reported equity could fall sharply, which may alter leverage metrics even without any change in debt. This distortion warrants further investigation before treating the current D/E as a reliable measure of financial resilience.